Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of INSYS Therapeutics Inc (NASDAQ: INSY) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of INSYS Therapeutics Inc (NASDAQ: INSY) concerning whether a series of statements by INSYS Therapeutics Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 26, 2017, the U.S. Department of Justice announced that John N. Kapoor, the company's founder was arrested in Arizona. He was charged with RICO conspiracy, as well as other felonies, including conspiracy to commit mail and wire fraud and conspiracy to violate the Anti-Kickback Law.

Specifically, the superseding indictment alleges that Kapoor and several other of Insys’ former officers “conspired to bribe practitioners in various states […] in order to get them to prescribe a fentanyl-based pain medication.” The medication in question, Subsys, “is a powerful narcotic intended to treat cancer patients suffering intense breakthrough pain.”

On this news, NASDAQ: INSY dropped almost 22.64 percent to close at $5.74 on October 26, 2017.

Based in Chandler, Arizona, INSYS Therapeutics Inc is a specialty pharmaceutical company, develops and commercializes supportive care products.

If you purchased shares of INSYS Therapeutics Inc (NASDAQ: INSY) on or before October 26, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185